2x ASTAR JDM H13 Bulbs Beam Lo Hi Kit Headlight White 6500K 7000LM LED ZES 9008 Car & Truck LED Light Bulbs


  1. Home
  2. 2x ASTAR JDM H13 Bulbs Beam Lo Hi Kit Headlight White 6500K 7000LM LED ZES 9008
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
JDM ASTAR 2x H13 9008 ZES LED 7000LM 6500K White Headlight Kit Hi Lo Beam Bulbs
Condition: New Brand:

JDM ASTAR

Warranty: 1 Year Manufacturer Part Number:

Does Not Apply

UPC:

643377474533

Interchange Part Number: LUMIEDS ZES Chip > Philips and CREE Lights
EAN:

0643377474533

Other Part Number: Conversion from Halogen / Aftermarket HID Xenon
Part Brand: High Low Beam Plug and Play Aluminum Bulbs 2PCS Placement on Vehicle: Front, Left, Right
Surface Finish: Light Weight Easy Install IP65 Waterproof Slim
published on tue nov 09 2021

2x ASTAR JDM H13 Bulbs Beam Lo Hi Kit Headlight White 6500K 7000LM LED ZES 9008 Car & Truck LED Light Bulbs

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

2x ASTAR JDM H13 Bulbs Beam Lo Hi Kit Headlight White 6500K 7000LM LED ZES 9008 Car & Truck LED Light Bulbs

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS